EGFR and gastric cancer: Although oncogenic mutations of Ras are infrequent (2–7%) in gastric cancer [24]; we nevertheless found evidence for variably activated GTP-Ras in most of the gastric cancer cell lines we used in this experiment (Figure 1b), possibly due to upstream activation of receptors such as EGFR, which is often mutated in gastric cancer.